Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
310 |
|
Actual shortage: | 12 (4%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 5 (2%) | |
Resolved: | 293 (95%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
48 (15%) |
|
Overdue reports |
4 (33%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-05-15 | 2022-08-09 | 160653 |
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-09-01 | 2022-10-02 | 168499 |
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2023-01-16 | 2023-05-01 | 181139 |
VORICONAZOLE FOR INJECTION | 200MG | POWDER FOR SOLUTION | Resolved | 2022-02-08 | 2022-12-04 | 154479 |
ERTAPENEM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2022-02-08 | 2022-09-21 | 154473 |
LEVOTHYROXINE SODIUM INJECTION | 40MCG | SOLUTION | Resolved | 2022-11-03 | 2023-03-10 | 173469 |
LEVOTHYROXINE SODIUM INJECTION | 100MCG | SOLUTION | Resolved | 2022-11-03 | 2023-03-02 | 173475 |
FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2022-10-02 | 2023-01-16 | 170878 |
FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2023-08-03 | 2023-08-31 | 201035 |
FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2023-10-03 | 2023-11-17 | 205907 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0